1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing chronic diseases and adoption of advanced devices for insulin delivery
5.1.1.2. Increasing diabetic population & obese population
5.1.1.3. Technological advancements in insulin delivery systems
5.1.2. Restraints
5.1.2.1. Technological advancements in insulin delivery systems
5.1.3. Opportunities
5.1.3.1. Rising consumer awareness about the latest insulin delivery devices
5.1.3.2. Collaboration of public and private sectors to meet diabetes needs
5.1.3.3. Technological advancements and rising product launches
5.1.4. Challenges
5.1.4.1. Stringent government rules and regulations governing the product approval process
5.2. Cumulative Impact of COVID-19

6. Insulin Delivery System Market, by Product Type
6.1. Introduction
6.2. Insulin Jet Injectors
6.3. Insulin Pens
6.4. Insulin Pumps
6.5. Syringes

7. Insulin Delivery System Market, by End User
7.1. Introduction
7.2. Hospitals
7.3. Retail channels
7.4. Specialty Diabetic Clinics

8. Americas Insulin Delivery System Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Insulin Delivery System Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Insulin Delivery System Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Animas Corporation (Johnson and Johnson)
12.2. Becton, Dickinson and Company
12.3. Biocon Limited
12.4. Eli Lilly and Company
12.5. Insulet Corporation
12.6. Medtronic PLC
12.7. Novo Nordisk A/S
12.8. Sanofi
12.9. Tandem Diabetes Care, Inc.
12.10. Ypsomed Holding AG

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL INSULIN DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 6. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, 2018-2027 (USD BILLION)
FIGURE 13. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 15. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2020 VS 2027 (USD BILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2027
FIGURE 17. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 23. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 24. ARGENTINA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 25. BRAZIL INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 26. CANADA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 27. MEXICO INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 28. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 29. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 30. AUSTRALIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 31. CHINA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 32. INDIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 33. INDONESIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 34. JAPAN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. MALAYSIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. PHILIPPINES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. SINGAPORE INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. SOUTH KOREA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. TAIWAN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. THAILAND INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. FRANCE INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. GERMANY INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. ITALY INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. NETHERLANDS INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. QATAR INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. RUSSIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. SAUDI ARABIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. SOUTH AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. SPAIN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. UNITED ARAB EMIRATES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. UNITED KINGDOM INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. GLOBAL INSULIN DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 54. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSULIN DELIVERY SYSTEM MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN JET INJECTORS, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SYRINGES, BY REGION, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY RETAIL CHANNELS, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL INSULIN DELIVERY SYSTEM MARKET SIZE, BY SPECIALTY DIABETIC CLINICS, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. AMERICAS INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 13. ARGENTINA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 14. BRAZIL INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 15. CANADA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 16. MEXICO INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 17. UNITED STATES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 18. ASIA-PACIFIC INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 19. AUSTRALIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. CHINA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. INDIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. INDONESIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. JAPAN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. MALAYSIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. PHILIPPINES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. SINGAPORE INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. SOUTH KOREA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. TAIWAN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. THAILAND INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. FRANCE INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. GERMANY INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. ITALY INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. NETHERLANDS INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. QATAR INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. RUSSIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. SAUDI ARABIA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. SOUTH AFRICA INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. SPAIN INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. UNITED ARAB EMIRATES INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. UNITED KINGDOM INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SCORES
TABLE 43. GLOBAL INSULIN DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 44. GLOBAL INSULIN DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 45. GLOBAL INSULIN DELIVERY SYSTEM MARKET: RANKING
TABLE 46. GLOBAL INSULIN DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 47. GLOBAL INSULIN DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 48. GLOBAL INSULIN DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 49. GLOBAL INSULIN DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 50. GLOBAL INSULIN DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 51. GLOBAL INSULIN DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 52. GLOBAL INSULIN DELIVERY SYSTEM MARKET: LICENSE & PRICING

Companies Mentioned

Animas Corporation (Johnson and Johnson)
Becton, Dickinson and Company
Biocon Limited
Eli Lilly and Company
Insulet Corporation
Medtronic PLC
Novo Nordisk A/S
Sanofi
Tandem Diabetes Care, Inc.
Ypsomed Holding AG